Treatment of mycotic aortic aneurysms with endoluminal grafts

Eur J Vasc Endovasc Surg. 2005 Feb;29(2):139-44. doi: 10.1016/j.ejvs.2004.11.008.

Abstract

Purpose: To report the benefit of endoluminal repair of mycotic aortic aneurysms and highlight the need for a registry.

Methods: Nine patients (five female) were identified over 5 years (1998-2003) as having presumed mycotic aortic aneurysms (12 in total) suitable for endoluminal grafting. A total of nine thoracic and three abdominal were grafted and followed up for a median of 36 months.

Results: Six of the aneurysms have resolved and one was converted to an open repair. There was one early death from rupture of a second undiagnosed aneurysm and two late deaths from rupture due to persistent inflammation. Long-term antibiotics have not been mandatory to ensure survival.

Conclusions: Mycotic aortic aneurysms of the thoracic and abdominal aorta do benefit from endoluminal repair, particularly when arising in previously normal aortic tissue. Endoluminal grafting also has a role in the palliation of secondarily infected aortas and so to prove its efficacy in the treatment of all these rare cases a registry is required.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Aneurysm, False / microbiology
  • Aneurysm, False / mortality
  • Aneurysm, False / therapy*
  • Aneurysm, Infected / mortality
  • Aneurysm, Infected / therapy*
  • Anti-Bacterial Agents / therapeutic use
  • Aortic Aneurysm / microbiology
  • Aortic Aneurysm / mortality
  • Aortic Aneurysm / therapy*
  • Blood Vessel Prosthesis
  • Blood Vessel Prosthesis Implantation / methods*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Stents*
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents